| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.249 | 37.610 | 23.371 | -312 | 2.473 | 9.870 | 6.450 | 7.025 | 7.004 | 2.895 |
| Total Income - EUR | 42.252 | 40.665 | 23.371 | -312 | 5.724 | 9.870 | 6.450 | 7.025 | 7.004 | 2.895 |
| Total Expenses - EUR | 35.843 | 31.738 | 21.294 | 328 | 931 | 1.955 | 2.281 | 1.877 | 1.872 | 1.521 |
| Gross Profit/Loss - EUR | 6.409 | 8.928 | 2.078 | -640 | 4.793 | 7.915 | 4.170 | 5.148 | 5.132 | 1.374 |
| Net Profit/Loss - EUR | 5.141 | 8.175 | 1.844 | -640 | 4.719 | 7.635 | 3.999 | 4.948 | 4.933 | 1.133 |
| Employees | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Akyta Med Trans Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.523 | 68 | 67 | 65 | 64 | 1.148 | 651 | 180 | 179 | 61 |
| Current Assets | 12.969 | 6.791 | 3.393 | 563 | 3.067 | 6.838 | 11.005 | 10.382 | 10.350 | 4.365 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.271 | 5.095 | 394 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 9.697 | 1.697 | 2.999 | 563 | 3.067 | 6.838 | 11.005 | 10.382 | 10.350 | 4.365 |
| Shareholders Funds | -11.396 | -3.104 | -1.208 | -1.825 | 2.929 | 7.788 | 11.615 | 10.515 | 10.483 | 3.932 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 28.009 | 10.123 | 4.947 | 2.729 | 471 | 198 | 42 | 47 | 46 | 494 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Akyta Med Trans Srl